ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 896,53
-1,32%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biogen Inc (BIIB)

  7. Biogen Inc (BIIB) Actualités

BIIB Biogen Inc

208,50
6,04 (2,98%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Biogen Inc BIIB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
6,04 2,98% 208,50 01:47:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
201,22 199,10 210,83 208,90 202,46
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202401:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
06/3/202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/3/202422:15GLOBEBiogen Highlights New Data at the International Conference..
27/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
22/2/202416:12EDGAR2Form 144 - Report of proposed sale of securities
22/2/202403:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:24EDGAR2Form 144 - Report of proposed sale of securities
21/2/202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202413:07EDGAR2Form 8-K - Current report
13/2/202401:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202401:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
12/2/202417:10EDGAR2Form 144 - Report of proposed sale of securities
10/2/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202313:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202315:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202312:30BWZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

Dernières Valeurs Consultées

NASDAQ
BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés